Recombinant IL-2 therapies in the clinic for cancer & HIV

被引：0
|
作者：
Pramik, MJ
机构：
来源：
GENETIC ENGINEERING NEWS | 1997年 / 17卷 / 19期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1 / &
相关论文
共 50 条
  • [41] CLINICAL CANCER-THERAPY WITH IL-2
    HERBERMAN, R
    CANCER INVESTIGATION, 1989, 7 (05) : 515 - 516
  • [42] Engineering IL-2 for immunotherapy of autoimmunity and cancer
    Rosmely Hernandez
    Janika Põder
    Kathryn M. LaPorte
    Thomas R. Malek
    Nature Reviews Immunology, 2022, 22 : 614 - 628
  • [43] INHIBITION OF HIV-1 RNA PRODUCTION BY THE DIPHTHERIA TOXIN-RELATED IL-2 FUSION PROTEINS DAB(486)IL-2 AND DAB(389)IL-2
    ZHANG, L
    WATERS, C
    NICHOLS, J
    CRUMPACKER, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1992, 5 (12) : 1181 - 1187
  • [44] Locoregional IL-2 immunotherapy of bladder cancer
    Santoni, A
    Velotti, F
    Giuffrida, A
    Santoni, G
    Piccoli, M
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1997, 19 (01) : 1 - 13
  • [45] Antitumor Effect of IL-2 and TRAIL Proteins Expressed by Recombinant Salmonella in Murine Bladder Cancer Cells
    de Lima Fragelli, Bruna Dias
    Camillo, Luciana
    de Almeida Rodolpho, Joice Margareth
    de Godoy, Krissia Franco
    de Castro, Cynthia Aparecida
    Brassolatti, Patricia
    da Silva, Adilson Jose
    Borra, Ricardo Carneiro
    Anibal, Fernanda de Freitas
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (04) : 460 - 476
  • [46] IMPROVING THE RAPIDITY OF HUMAN RECOMBINANT INTERLEUKIN-2 (IL-2) QUANTITATION
    WANG, KC
    LEUNG, BS
    HERBERMAN, RB
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 376 - 376
  • [47] INTRAPLEURAL RECOMBINANT IL-2 IN PASSIVE IMMUNOTHERAPY FOR MALIGNANT PLEURAL EFFUSION
    ASTOUL, P
    VIALLAT, JR
    LAURENT, JC
    BRANDELY, M
    BOUTIN, C
    CHEST, 1993, 103 (01) : 209 - 213
  • [48] INVIVO EFFECTS OF RECOMBINANT IL-2 .1. ISOLATION OF CIRCULATING LEU-19+ LYMPHOKINE-ACTIVATED KILLER EFFECTOR-CELLS FROM CANCER-PATIENTS RECEIVING RECOMBINANT IL-2
    MCMANNIS, JD
    FISHER, RI
    CREEKMORE, SP
    BRAUN, DP
    HARRIS, JE
    ELLIS, TM
    JOURNAL OF IMMUNOLOGY, 1988, 140 (04): : 1335 - 1340
  • [49] RECOMBINANT IL-2 THERAPY IN SEVERE COMBINED IMMUNODEFICIENCY DISEASE (SCID)
    PAHWA, R
    CHATILA, T
    DAY, NK
    PAHWA, S
    GEHA, R
    SCHWARTZ, SA
    PARADISE, C
    GOOD, RA
    CLINICAL RESEARCH, 1988, 36 (03): : A618 - A618
  • [50] COMPARATIVE TOXICITY AND PATHOLOGY ASSOCIATED WITH ADMINISTRATION OF RECOMBINANT IL-2 TO ANIMALS
    ANDERSON, TD
    HAYES, TJ
    POWERS, GD
    GATELY, MK
    TUDOR, R
    RUSHTON, A
    INTERNATIONAL REVIEW OF EXPERIMENTAL PATHOLOGY, 1993, 34 : 57 - 77
12345